Wells Fargo lowered the firm’s price target on Globe Life (GL) to $139 from $140 and keeps an Overweight rating on the shares. The firm notes the company brought down its full year margin guide for Health, but increased its margin guide for Life. Management sounded positive on the ability to reprice its med supp block and said it would see how the next quarters go in terms of seeking rate increase.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue